NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions

Megan D Radyk1,2, Barbara S Nelson1,3, Mariana Tannus Ruckert1

  • 1Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.

Nature Metabolism
|April 1, 2026
PubMed

Insights

Pancreatic metaplasia involves metabolic changes, particularly NRF2-target genes like G6PD and ME1, which regulate oxidative stress. Oxidative stress drives precancerous lesion formation, impacting pancreatic ductal adenocarcinoma progression.

Area of Science:

  • Metabolic reprogramming in cancer biology
  • Pancreatic cancer research
  • Cellular stress response mechanisms

Background:

  • Acinar-to-ductal metaplasia (ADM) is a reversible cell state crucial for pancreas repair.
  • Oncogenic KRAS mutations can drive ADM progression to pancreatic intraepithelial neoplasia (PanIN) and pancreatic ductal adenocarcinoma (PDAC).
  • Metabolic alterations in precancerous pancreatic lesions remain understudied.

Purpose of the Study:

  • To investigate global changes in central carbon metabolism during ADM formation.
  • To elucidate the role of NADPH-producing enzymes (G6PD, ME1) and oxidative stress in pancreatic precancerous lesions.
  • To understand the impact of metabolic reprogramming on PDAC progression.

Main Methods:

  • Analysis of central carbon metabolism genes and metabolites in ADM.
  • Utilizing mouse models of pancreatic tumorigenesis with G6PD or ME1 deficiency.
  • Pharmacological manipulation of oxidative stress and glutathione levels in vitro and in vivo.
  • Assessment of ADM, PanIN formation, and PDAC progression.

Main Results:

  • ADM formation is associated with significant changes in central carbon metabolism and induction of NRF2-target genes.
  • G6PD and ME1, key NADPH-producing enzymes, are involved in regulating oxidative stress.
  • G6PD deficiency or ME1 loss increases reactive oxygen species and lipid peroxidation, accelerating ADM and PanIN formation.
  • ME1 loss, unlike G6PD deficiency, accelerates PDAC progression.
  • Pharmacological antioxidant treatment attenuates ADM progression, while glutathione depletion promotes precancerous lesions.

Conclusions:

  • Oxidative stress is a required driver for ADM.
  • Metabolic reprogramming, particularly involving NADPH-producing enzymes and oxidative stress regulation, plays a critical role in pancreatic precancerous lesion development.
  • Targeting metabolic pathways offers potential therapeutic strategies for PDAC prevention and treatment.